"Following the recommendations of the Interagency Coordination Group on #AntimicrobialResistance, we have come together to advocate for urgent action to combat the threat of AMR, to reinvigorate global political momentum, & to catalyze action in an One Health approach"-@DrTedros
"It is critical that our discussions are followed up in countries and lead to real results. As #COVID19 has so harshly demonstrated, the world cannot afford another global crisis. We must act, and we must act together"-@DrTedros on #AntimicrobialResistance
"That means we need political leaders, the private sector and civil society working together, first to address the drivers of #AntimicrobialResistance"-@DrTedros
"We also need a coordinated approach to increase investment across the One Health spectrum in implementation of national action plans, and in research and development.
"This is not a task for the health sector alone. #AntimicrobialResistance is a problem for humans, animals, economic productivity, and the environment. The solutions, too, must span these sectors"-@DrTedros
World leaders are joining forces to fight the accelerating crisis of #AntimicrobialResistance. The One Health Global Leaders Group includes heads of government, ministers, leaders from the private sector & civil society.
Nurses educate patients & families on how to prevent infections at home & in their communities: Good hygiene can help stop the spread of drug resistance.
Nurses 👨⚕️, doctors 👩🏾⚕️ & other healthworkers should support people to continue to take their anti-malaria, TB & #HIV treatments to reduce the spread of drug resistance.
Nurses support patients in taking antimicrobial medicines properly. Taking the right medication for the right amount of time can help stop the spread of drug resistance.
In 2019, among under-5-year-olds 👦👧🏽:
✅144 million were stunted or wasted (too short or too thin)
✅ 47 million had low weight for height
✅38 million were overweight
🆕 – WHO updates its guidelines for #COVID19 care.
WHO recommends that patients who have had COVID-19 - both confirmed and suspected - should have access to follow-up care if they have persistent, new or changing symptoms bit.ly/3cctA1T
Evidence was gathered on the post COVID condition, so-called ‘long COVID’, where people who have recovered from #COVID19 continue to have longer-term issues like extreme fatigue, persistent cough and exercise intolerance.
Understanding this condition ('long COVID') is one of WHO’s priority areas of work.
In February 2021, WHO will organize a series of consultations to reach consensus on a description of this condition & its subtypes, and case definitions bit.ly/3cctA1T
"First of all, I would like to thank Your Excellency @drharshvardhan for your leadership as chair over the past week, and the past year.
And my thanks to all members of the Board for your dedication and attention over the past 8 days"-@DrTedros#EB148
"You have addressed an enormous range of issues, reflecting the huge scope of health challenges we face, and the huge scope of expectations the world has of WHO"-@DrTedros#EB148
"A year ago today, fewer than 1500 cases of #COVID19 had been reported to WHO, including just 23 cases outside #China.
This week, we expect to reach 100 million reported cases"-@DrTedros
"Numbers can make us numb to what they represent: every death is someone’s parent, someone’s partner, someone’s child, someone’s friend"-@DrTedros#COVID19
In fragile, conflict-affected and vulnerable settings, delivery of quality health services faces significant challenges. A 🆕 guide outlines 🔑 practical approaches aimed at saving lives & improving quality of care in these settings.
👉 bit.ly/3ommLO0
During humanitarian crises, protracted emergencies & armed conflicts, quality health services face challenges, incl.:
🔸service disruption
🔸increased demand on health services
🔸complex & unpredictable resourcing issues
🔸public health vulnerability
👶🧕👩🦰 in vulnerable settings have significant health needs. Estimates in settings where political conflict, displacement or natural disasters prevail indicate:
🔸 60% of preventable maternal deaths
🔸 53% of deaths in 🧒 aged <5
🔸 45% of neonatal deaths
#COVAX announced the signing of an advance purchase agreement for up to 40 million doses of the Pfizer-BioNTech #COVID19 vaccine bit.ly/396cCjQ
Pending WHO emergency use listings, nearly 150 million doses of the AstraZeneca/Oxford #COVID19 candidate vaccines are anticipated to be available by end of March 2021 bit.ly/396cCjQ
#COVAX is on track to deliver at least 2 billion #COVID19 doses by the end of the year, including at least 1.3 billion doses to 92 lower income economies in the @gavi COVAX Advanced Market Commitment bit.ly/396cCjQ